Dengue is a year-round risk in many parts of the world, with outbreaks commonly occurring every 2–5 years. Travelers to risk areas should prevent mosquito bites. Country List : Burkina Faso, Colombia, Ecuador, including the Galápagos Islands, Guatemala, Mexico, Panama, Sudan, Cuba, French Polynesia, including the island groups of Society Islands (Tahiti, Moorea, and Bora-Bora), Marquesas Islands (Hiva Oa and Ua Huka), and Austral Islands (Tubuai and Rurutu), Iran, Philippines, Saint Lucia, Pakistan, Guadeloupe, Brazil, Fiji

Many international destinations are reporting increased numbers of cases of measles. Country List : Afghanistan, Benin, Cameroon, Central African Republic, Chad, Côte d'Ivoire (Ivory Coast), Democratic Republic of the Congo, Djibouti, Ethiopia, Indonesia, Liberia, Nigeria, Pakistan, Republic of the Congo , Senegal, Somalia, Republic of South Sudan, Togo, Yemen, Kyrgyzstan, Armenia, Mauritania, Equatorial Guinea, Ghana, Kazakhstan, Burkina Faso, Türkiye (Turkey), United Arab Emirates, Burundi, Romania, Malaysia, Russia, Azerbaijan, Uzbekistan, Philippines, Austria, Belarus, Georgia, Bosnia and Herzegovina, San Marino, Guinea, Kenya, Monaco, United Kingdom, including England, Scotland, Wales, and Northern Ireland, Belgium, Ireland, Montenegro, Moldova, Serbia, Niger, Thailand, Guinea-Bissau, Libya, Mozambique, Saudi Arabia, Namibia, Sudan

Uganda is experiencing an outbreak of Sudan virus disease (SVD). SVD is a type of Ebola disease caused by infection with the Sudan virus.

There is an outbreak of chikungunya in Réunion. Mosquitoes spread the virus that causes chikungunya.

There is an outbreak of clade I mpox in Central and Eastern Africa. Country List : Burundi, Central African Republic, Democratic Republic of the Congo, Republic of the Congo , Rwanda, Uganda, Kenya, Zambia

In this trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-pressure target of less than 120 mm Hg than with a target of less than 140 mm Hg.

In a trial involving 135 participants with IgG4-related disease, inebilizumab was associated with significantly lower flare risk and greater likelihood of complete remission than placebo at 1 year.

In patients with chronic severe rhinosinusitis and nasal polyps, tezepelumab therapy led to greater reductions in polyp size and nasal congestion and less use of surgery and glucocorticoids than placebo.

Endoscopes have become invaluable devices for diagnostic and therapeutic procedures since their first use in 1853.1 These reusable medical devices perform over 250 million endoscopic procedures globally each year, with the number of procedures steadily increasing.2 To safely reuse endoscopes on multiple patients, these devices must undergo lengthy reprocessing steps according to the manufacturer’s instructions for use (IFU). These steps include cleaning, high-level disinfection or sterilization, drying, proper storage, and safe transport.

To assess the morbidity and absenteeism due to SARS-CoV-2 infection or influenza among healthcare personnel (HCP) in Greece in 2023-2024.

The impact of universal masking on transmission of endemic respiratory viruses in children’s hospitals is unknown. We compared the incidence rate, level and trend of non-SARS-CoV-2 healthcare-associated viral respiratory infections (HA-VRIs) prior to the COVID-19 pandemic (September 2013 - February 2020); during universal masking (May 2021 - March 2023); and after universal masking was lifted (April 2023 - November 2023). We found that universal masking was not associated with a change in non-SARS-CoV-2 HA-VRIs.